Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Immunocore Holdings plc as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- +9 vs. Q1 2022
- Shares held
- 21.0M
- +1.30M (+6.6%) vs. Q1 2022
- Total value
- $784.5M
- +$194.4M (+32.9%) vs. Q1 2022
- New holders
- 14
- 15 more added
- Sold out
- 5
- 18 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Beacon Capital Management, LLC | 250 | $7.00K | 0.00% | 00.0% | Unchanged |
| State of Wyoming | 215 | $8.00K | 0.00% | +52+31.9% | Added |
| Assetmark, Inc | 219 | $8.00K | 0.00% | +125+133.0% | Added |
| Tower Research Capital LLC (TRC) | 285 | $11.0K | 0.00% | +285 | New |
| Simplex Trading, LLC | 500 | $18.0K | 0.00% | −186−27.1% | Reduced |
| Advisor Group Holdings, Inc. | 584 | $21.0K | 0.00% | 00.0% | Unchanged |
| Veritas Investment Partners (UK) Ltd. | 575 | $21.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 776 | $29.0K | 0.00% | −332−30.0% | Reduced |
| Royal Bank of Canada | 2,658 | $99.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,813 | $105.0K | 0.00% | −4,019−58.8% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,864 | $144.0K | 0.00% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 6,419 | $239.0K | 0.04% | +6,419 | New |
| UBS Group AG | 7,096 | $265.0K | 0.00% | −1,312−15.6% | Reduced |
| Victory Capital Management Inc | 8,186 | $305.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 8,513 | $318.0K | 0.12% | +3,297+63.2% | Added |
| Parallax Volatility Advisers, L.P. | 8,556 | $319.0K | 0.00% | +8,556 | New |
| Dalton Investments LLC | 10,000 | $373.0K | 0.34% | +10,000 | New |
| State Street Corp | 11,834 | $442.0K | 0.00% | +11,834 | New |
| JPMorgan Chase & Co | 13,106 | $489.0K | 0.00% | +13,106 | New |
| Jump Financial, LLC | 13,200 | $492.0K | 0.02% | +13,200 | New |
| ETF Managers Group, LLC | 13,858 | $498.0K | 0.01% | +324+2.4% | Added |
| LMR Partners LLP | 15,000 | $560.0K | 0.01% | +15,000 | New |
| Legal & General Group Plc | 15,792 | $589.0K | 0.00% | −6,577−29.4% | Reduced |
| Geode Capital Management, LLC | 16,464 | $614.0K | 0.00% | +6,989+73.8% | Added |
| Millennium Management LLC | 19,178 | $716.0K | 0.00% | +19,178 | New |
| Manufacturers Life Insurance Company, The | 21,793 | $782.4K | 0.00% | 00.0% | Unchanged |
| Vident Investment Advisory, LLC | 22,912 | $854.0K | 0.03% | −13,899−37.8% | Reduced |
| Morgan Stanley | 23,347 | $871.0K | 0.00% | +20,995+892.6% | Added |
| Marshall Wace, LLP | 24,120 | $900.0K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 25,200 | $940.0K | 0.01% | +25,200 | New |
| Alps Advisors Inc | 25,526 | $952.0K | 0.01% | −18,700−42.3% | Reduced |
| Waverton Investment Management Ltd | 27,330 | $1.02M | 0.04% | −10,000−26.8% | Reduced |
| TD Asset Management Inc | 27,506 | $1.03M | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 42,009 | $1.57M | 0.01% | +41,321+6,006.0% | Added |
| Jane Street Group, LLC | 48,464 | $1.81M | 0.00% | +48,464 | New |
| Renaissance Technologies LLC | 50,900 | $1.90M | 0.00% | +43,600+597.3% | Added |
| Omega Fund Management, LLC | 51,535 | $1.92M | 0.61% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 57,409 | $2.14M | 0.00% | +57,409 | New |
| UBS Oconnor LLC | 57,497 | $2.15M | 0.02% | +57,497 | New |
| CWM, LLC | 73,036 | $2.73M | 0.02% | +73,036 | New |
| Citadel Advisors LLC | 84,500 | $3.15M | 0.00% | +24,774+41.5% | Added |
| Pier Capital, LLC | 123,394 | $4.60M | 0.79% | −113,222−47.9% | Reduced |
| OrbiMed Advisors LLC | 131,100 | $4.89M | 0.10% | +3,000+2.3% | Added |
| Rhenman & Partners Asset Management AB | 140,000 | $5.22M | 0.59% | −30,472−17.9% | Reduced |
| Samsara BioCapital, LLC | 160,963 | $6.01M | 1.61% | 00.0% | Unchanged |
| Rathbone Brothers plc | 190,015 | $7.09M | 0.08% | 00.0% | Unchanged |
| Bain Capital Public Equity Management II, LLC | 249,318 | $9.30M | 0.54% | −68,358−21.5% | Reduced |
| Armistice Capital, LLC | 268,000 | $10.0M | 0.26% | +88,000+48.9% | Added |
| Schroder Investment Management Group | 280,361 | $10.1M | 0.02% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 293,385 | $10.9M | 11.60% | 00.0% | Unchanged |
| Principal Financial Group Inc | 299,950 | $11.2M | 0.01% | +64,405+27.3% | Added |
| Price T Rowe Associates Inc | 313,899 | $11.7M | 0.00% | −29,380−8.6% | Reduced |
| Massachusetts Financial Services Co | 339,942 | $12.7M | 0.00% | −2,536−0.7% | Reduced |
| Thrivent Financial for Lutherans | 369,504 | $13.8M | 0.04% | −18,190−4.7% | Reduced |
| Tang Capital Management LLC | 385,600 | $14.4M | 2.18% | 00.0% | Unchanged |
| BlackRock Inc. | 496,182 | $18.5M | 0.00% | 00.0% | Unchanged |
| Bill & Melinda Gates Foundation | 576,923 | $21.5M | 16.53% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 667,417 | $24.9M | 4.97% | +168,227+33.7% | Added |
| First Manhattan Co | 795,849 | $29.7M | 0.12% | −12,700−1.6% | Reduced |
| General Atlantic LLC | 950,000 | $35.4M | 0.46% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,265,912 | $47.2M | 0.01% | −76,447−5.7% | Reduced |
| Avidity Partners Management LP | 1,350,000 | $50.4M | 1.16% | −13,800−1.0% | Reduced |
| FMR LLC | 1,360,384 | $50.8M | 0.01% | −267,171−16.4% | Reduced |
| Baker Bros. Advisors LP | 2,520,730 | $94.0M | 0.53% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 2,671,652 | $99.7M | 2.90% | +119,618+4.7% | Added |
| RTW Investments, LP | 3,996,154 | $149.1M | 3.85% | +2,136,683+114.9% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −407,058−100.0% | Sold out |
| Samlyn Capital, LLC | 0 | $0 | 0.00% | −380,811−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −53,878−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −52,174−100.0% | Sold out |